Stoke Therapeutics, Inc. ($STOK)
Allan Jonathan โ GENERAL COUNSEL & CORP SEC
Shares
8,692
Price
$33.64
Total Value
$292,358.90
Nearby Earnings
Mar 17, 2026
EPS:-0.99 (est: -0.92)+8.1%
Revenue:$1.40M (est: $6.24M)-77.5%
Mar 24, 2026
EPS:Est: -0.93
Revenue:Est: $6.24M
Transaction Details
| Insider | Allan Jonathan |
|---|---|
| Title | GENERAL COUNSEL & CORP SEC |
| Transaction Date | Mar 20, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Mar 24, 2026 |
| Shares Sold | 8,692 |
| Price per Share | $33.64 |
| Total Value | $292,358.90 |
| Shares Owned After | 20,144 |
| Derivative | No |
| Accession Number | 0001966716-26-000008 |
| Document | View SEC Filing |